Chinese medicine capsule for treating cardiac and cerebral vascular diseases and its production process

Abstract

The Chinese medicine capsule for treating cardiac and cerebral vascular diseases is prepared with wall breaking gastrodia tuber spore powder, angelica, Chuanxiong rhizome, red peony root, peach kernel and other 17 kinds of Chinese medicinal materials. The preparation process includes grinding wall breaking gastrodia tuber spore into fine powder, dividing the other Chinese medicinal materials into two parts, decocting one part of the Chinese medicinal materials and concentrating the medicine liquid into extractum, grinding the other part of the Chinese medicinal materials into fine powder, mixing, drying to water content less than 3 %, sterilizing and encapsulating. The Chinese medicine capsule has high curative effect, simple preparation process and easy taking.

Description

1. Technical Field

[0001] The invention relates to a Chinese medicine capsule for treating cardiovascular and cerebrovascular diseases for clinical use and a production method thereof. 2. Background technology

[0002] Cardiovascular and cerebrovascular diseases are common and frequently-occurring diseases, which seriously affect people's health and life safety. Its manifestations are mostly myocardial infarction, thrombosis in the coronary artery, temperament changes caused by changes in the blood quality of the heart, cerebral hemorrhage, acute stroke and stroke sequelae due to cerebral ischemia.

[0003] The incidence of myocardial infarction is relatively high in Europe and the United States. According to the data of 26 years of follow-up in Europe and the United States, the incidence of men aged 35-84 is 71‰ and that of women is 22‰. Among them, the incidence of men aged 55-64 is 91‰ and women are 25‰. ‰; 65-70 year old group, male is 119‰, female is 51‰; 75-84 year old grou...

Examples

Embodiment Construction

[0008] The specific embodiments of the present invention will be described in detail below in combination with specific situations.

[0009] Given the foregoing technical solution, the present invention is made by adopting the following formulas in specific implementation, which is calculated as a percentage by weight:

[0010] Angelica 4.4-6.1%, Chuanxiong 4.4-6.1%, Red peony 4.4-6.1%, Peach kernel 3.2-3.9%, Salvia 4.4-6.1%, Leech 3.2-3.9%, Safflower 2.3-2.9%, Scorpion 3.2-3.9% , Gentian 4.4-6.1%, Uncaria 4.4-6.1%, Gastrodia spore-breaking powder 4.4-6.1%, Rhubarb 4.4-6.1%, Dannanxing 2.2-2.8%, Habitat 3.2-3.9%, Scrophulariaceae 3.2- 3.9%, mulberry parasitic 3.2-3.9%, antelope horn powder 3.2-3.9%, calamus 4.4-6.1%, astragalus 7.9-9.6%, ginseng 3.2-3.9%, spatholobi 4.4-6.1%, and Achyranthes bidentata 4.4- 6.1%, the total amount is 100%; in practice, the capsules of the present invention are preferably used in percent by weight:

[0011] Angelica 5.2539%, Ligusticum chuanxiong 5.2...

1. Technical Field

[0001] The invention relates to a Chinese medicine capsule for treating cardiovascular and cerebrovascular diseases for clinical use and a production method thereof. 2. Background technology

[0002] Cardiovascular and cerebrovascular diseases are common and frequently-occurring diseases, which seriously affect people's health and life safety. Its manifestations are mostly myocardial infarction, thrombosis in the coronary artery, temperament changes caused by changes in the blood quality of the heart, cerebral hemorrhage, acute stroke and stroke sequelae due to cerebral ischemia.

[0003] The incidence of myocardial infarction is relatively high in Europe and the United States. According to the data of 26 years of follow-up in Europe and the United States, the incidence of men aged 35-84 is 71‰ and that of women is 22‰. Among them, the incidence of men aged 55-64 is 91‰ and women are 25‰. ‰; 65-70 year old group, male is 119‰, female is 51‰; 75-84 year old grou...

Examples

Embodiment Construction

[0008] The specific embodiments of the present invention will be described in detail below in combination with specific situations.

[0009] Given the foregoing technical solution, the present invention is made by adopting the following formulas in specific implementation, which is calculated as a percentage by weight:

[0010] Angelica 4.4-6.1%, Chuanxiong 4.4-6.1%, Red peony 4.4-6.1%, Peach kernel 3.2-3.9%, Salvia 4.4-6.1%, Leech 3.2-3.9%, Safflower 2.3-2.9%, Scorpion 3.2-3.9% , Gentian 4.4-6.1%, Uncaria 4.4-6.1%, Gastrodia spore-breaking powder 4.4-6.1%, Rhubarb 4.4-6.1%, Dannanxing 2.2-2.8%, Habitat 3.2-3.9%, Scrophulariaceae 3.2- 3.9%, mulberry parasitic 3.2-3.9%, antelope horn powder 3.2-3.9%, calamus 4.4-6.1%, astragalus 7.9-9.6%, ginseng 3.2-3.9%, spatholobi 4.4-6.1%, and Achyranthes bidentata 4.4- 6.1%, the total amount is 100%; in practice, the capsules of the present invention are preferably used in percent by weight:

[0011] Angelica 5.2539%, Ligusticum chuanxiong 5.2...